Asia
Shenzhen New Industries Biomedical's Attributable Profit Rises 13% in H1; Shares Rise 4%
Shenzhen New Industries Biomedical Engineering's (SHE:300832) attributable profit rose 13% to 867.7 million yuan in the first half from 771.1 million yuan in the year-ago period, according to a Friday filing with the Shenzhen Stock Exchange.Earnings per share at the clinical laboratory instrument manufacturer increased to 1.1057 yuan from 0.9814 yuan in the prior-year period.Operating revenue grew 11% year over year to 2.42 billion yuan from 2.18 billion yuan.Shares rose 4% during afternoon trading on Friday.
SHE:300832
